JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'p53 and mdm2 proteins interaction inhibitor racemic'

Search results for: 'p53 and mdm2 proteins interaction inhibitor racemic'

A8317 Fludarabine Phosphate (Fludara)

2 Citation

Target: STAT

Summary: Inhibits STAT1 activation and DNA synthesis

insoluble in EtOH; ≥17.6 mg/mL
A8183 Trichostatin A (TSA)

13 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor

insoluble in H2O; ≥15.12 mg/mL
A4090 JNJ-26481585

3 Citation

Target: Histone Deacetylases (HDACs)

Summary: Potent HDAC inhibitor

insoluble in H2O; insoluble in EtOH; ≥19.2 mg/mL
A4089 Mocetinostat (MGCD0103, MG0103)

2 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor,isotype-selective and potent

insoluble in EtOH; insoluble in H2O; ≥19.8 mg/mL
A2171 Carboplatin

Summary: Antitumor agent that forms platinum-DNA adducts.

insoluble in ETOH; ≥9.28 mg/mL
A2187 Cladribine

Target: Adenosine Deaminases

Summary: Apoptosis inducer in CLL cells

≥41.67 mg/mL
A2451 Epirubicin HCl

Target: Topoisomerases

Summary: Antibiotic antitumor agent

≥29.00 mg/mL
A3738 PSI-7977

Target: HCV polymerase

Summary: Antiviral agents for chronic HCV infection

insoluble in H2O; ≥183 mg/mL
A8802 (S)-Crizotinib

4 Citation

Target: MTH1

Summary: Potent MTH1 inhibitor

≥33.33 mg/mL
A1402 Gemcitabine HCl

Summary: Inhibits DNA synthesis,deoxycytidine analog

≥10.1 mg/mL